1. Home
  2. ADVM vs LGO Comparison

ADVM vs LGO Comparison

Compare ADVM & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADVM
  • LGO
  • Stock Information
  • Founded
  • ADVM 2006
  • LGO 1988
  • Country
  • ADVM United States
  • LGO Canada
  • Employees
  • ADVM N/A
  • LGO N/A
  • Industry
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • LGO
  • Sector
  • ADVM Health Care
  • LGO
  • Exchange
  • ADVM Nasdaq
  • LGO Nasdaq
  • Market Cap
  • ADVM 119.6M
  • LGO 134.0M
  • IPO Year
  • ADVM 2014
  • LGO 2007
  • Fundamental
  • Price
  • ADVM $4.74
  • LGO $1.74
  • Analyst Decision
  • ADVM Strong Buy
  • LGO Strong Buy
  • Analyst Count
  • ADVM 6
  • LGO 1
  • Target Price
  • ADVM $27.83
  • LGO $4.20
  • AVG Volume (30 Days)
  • ADVM 226.5K
  • LGO 146.4K
  • Earning Date
  • ADVM 11-04-2024
  • LGO 11-12-2024
  • Dividend Yield
  • ADVM N/A
  • LGO N/A
  • EPS Growth
  • ADVM N/A
  • LGO N/A
  • EPS
  • ADVM N/A
  • LGO N/A
  • Revenue
  • ADVM $1,000,000.00
  • LGO $144,822,000.00
  • Revenue This Year
  • ADVM N/A
  • LGO N/A
  • Revenue Next Year
  • ADVM $1,342.84
  • LGO $37.73
  • P/E Ratio
  • ADVM N/A
  • LGO N/A
  • Revenue Growth
  • ADVM N/A
  • LGO N/A
  • 52 Week Low
  • ADVM $4.59
  • LGO $1.38
  • 52 Week High
  • ADVM $29.70
  • LGO $2.84
  • Technical
  • Relative Strength Index (RSI)
  • ADVM 26.02
  • LGO 37.89
  • Support Level
  • ADVM $4.59
  • LGO $1.64
  • Resistance Level
  • ADVM $4.89
  • LGO $1.84
  • Average True Range (ATR)
  • ADVM 0.31
  • LGO 0.11
  • MACD
  • ADVM -0.06
  • LGO -0.03
  • Stochastic Oscillator
  • ADVM 9.80
  • LGO 16.39

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.

Share on Social Networks: